Ann: Impact of COVID-19 Stage 4 Restrictions, page-39

A rather incisive yet qualified analysis of the current situation.

The bull elephant in the room still remains that ECT cannot build anything that makes returns for shareholders (ie. income) even after 10+ years of throwing money at one idea after another. They have survived (only just to this point) through issuing billions of confetti script that is now almost worthless, expired options, loans from some big shareholders, token government handouts and other meagre contributions. They have racked up countless gunna do this and gunna do that engineering plans for ad nauseum building and upgrading that has yielded between negligible to zero income returns with absolute zero yield for shareholders - all written up if one cares to trawl back through 10+ years of annual reports and AGM chook feed.

ECT belongs in some old-world government run research institution living off a bottomless account of slush funding and NOT in the sink-or-swim commercial world of making real money within specified time frames in order to innovate,specify, build, produce, survive and grow investor returns and where each person in the business is accountable for delivering real economic returns that are significantly greater than the wages they are paid and the costs of running the business.